WHA73: Written statement of KEI – Agenda item 3 – Address by WHO Director-General devoted to the COVID-19 pandemic response in advance of the opening of the Health Assembly

KEI is an accredited non-state actor at the World Health Organization (WHO). This is our statement at the 73rd World Health Assembly. https://extranet.who.int/nonstateactorsstatements/meetingoutline/6 Knowledge Ecology International Meeting: Seventy-third World Health Assembly Written statements on COVID-19 pandemic The biggest question today… Continue Reading

WHO member states poised to adopt weaker than needed COVID-19 resolution after tortuous negotiations

UPDATE: The World Health Organization has published the COVID-19 response resolution as a conference paper (A73/CONF./1) marked with the date of 18 May 2020. The sponsors of the draft resolution included: Albania, Australia, Bahrain, Bangladesh, Belarus, Bhutan, Bolivia (Plurinational State… Continue Reading

Patents related to PX-UV, an R2-D2 look-alike robot that may disinfect public spaces from SARS-CoV-2

Texas-based company Xenex Disinfection Services, a manufacturer of robots that reportedly removes the SARS-CoV-2 virus from public spaces, has been making news lately. One of their robots, which uses ultraviolet lights to kill viruses and bacteria in surfaces and look… Continue Reading

14 May 2020 – The WHO Covid-19 Technology Pool: The solution to ensure global access to Covid-19 health technologies

Livestream here: https://www.youtube.com/watch?v=iNMpuQfH088 On 14 May 2020, Health Action International, Knowledge Ecology International, Medicines Law & Policy, Pharmaceutical Accountability Foundation, and Wemos will convene a briefing entitled: “The WHO Covid-19 Technology Pool: The solution to ensure global access to Covid-19… Continue Reading

Comments of Knowledge Ecology International Regarding “Purple Book Enhancement; Establishment of a Public Docket; Request for Comments” (FDA-2020-N-0437)

May 4, 2020 Comments of Knowledge Ecology International Regarding “Purple Book Enhancement; Establishment of a Public Docket; Request for Comments” (FDA-2020-N-0437) Knowledge Ecology International (KEI) provides the following comments regarding the Food and Drug Administration [FDA]’s Purple Book Enhancement. Our… Continue Reading

Copyright and related rights issues in the USTR Special 301 Report 2020

Since 1974, the “Special 301 Report” (the Report) provides an annual review of the state of intellectual property protection and enforcement among U.S. trading partners around the world. Amended in 1988 by Congress, the Trade Act is “to provide for… Continue Reading

KEI Comments on NIH Exclusive License to Kriya Therapeutics for Diabetes and Obesity Treatment

On Tuesday April 28, 2020, KEI submitted comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License: AAV Mediated Exendin-4 Gene Transfer to Salivary Glands To Protect Subjects From Diabetes or Obesity” (85… Continue Reading